Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
Keryx Biopharma (KERX) Pulls-Back After Ripping Over 160% on Zerenex DAta
February 1, 2013 11:54 AM ESTLooks like the ride for Keryx Biopharmaceuticals Inc. (KERX) might be coming to a close.
After moving up 165 percent this week through Thursday, shares of Keryx are retracing a bit today. The stock is down over 15 percent on volume as traders look to cash out on some... More
Keryx Biopharma (KERX) Prices 8.23M Offering at $8.49/Share
January 31, 2013 6:53 AM ESTKeryx Biopharmaceuticals, Inc. (NASDAQ: KERX) announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share. In connection with this offering, Keryx granted to the underwriters a 30-day option to purchase 1,235,100 additional shares of... More